Conference Call Scheduled for Today, February 3, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $64.2 million increased 6% sequentially compared to first quarter Net loss was $0.1 million, or $0.00 per basic and diluted share Management provides […]
Tag: Cardiovascular Systems
Cardiovascular Systems, Inc. Announces Sachin H. Jain, MD, MBA, Joins Board of Directors
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Sachin H. Jain, MD, […]
Cardiovascular Systems, Inc. Receives CE Mark for Diamondback 360® Coronary Orbital Atherectomy System
One solution to both reduce surface calcium and fracture deep calcium ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced […]
Cardiovascular Systems, Inc. Reports Fiscal 2021 First-Quarter Financial Results
Conference Call Scheduled for Today, November 4, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $60.5 million increased 42% sequentially and decreased 6.1% compared to last year Net loss was $2.1 million, or $0.05 per basic and diluted […]
Cardiovascular Systems Announces Presentation of Data From Large Coronary Orbital Atherectomy Study at the TCT Connect 2020 Conference
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observational study of coronary […]
Cardiovascular Systems, Inc. Reports Fiscal 2020 Fourth-Quarter Financial Results
Conference Call Scheduled for Today, August 4, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $42.5 million decreased 37.6% from fourth quarter last year Net loss was $15.2 million, or $0.43 per basic and diluted share Fiscal year […]
Cardiovascular Systems Presents REACH PVI Study at the New Cardiovascular Horizons Conference
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the results from its REACH PVI study were presented […]
Cardiovascular Systems Announces Exercise of Underwriters’ Option
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the underwriters of its recent public offering of common […]
Cardiovascular Systems Prices Public Offering of Common Stock
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the pricing of its previously announced underwritten public offering of […]
Cardiovascular Systems, Inc. Reports Fiscal 2020 Second-Quarter Financial Results
Conference Call Scheduled for Today, February 5, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $68.3 million increased 13.5% from second quarter last year Net loss was $3.4 million, or $0.10 per basic and diluted share Company raises […]
